Hydroxyurea Patent Expiration

Hydroxyurea was first introduced by Waylis Therapeutics Llc in its drug Hydrea on Approved Prior to Jan 1, 1982. Other drugs containing Hydroxyurea are Siklos, Droxia, Xromi. 9 different companies have introduced drugs containing Hydroxyurea.


Hydroxyurea Patents

Given below is the list of patents protecting Hydroxyurea, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Xromi US12409156 Dec 23, 2041 Nova Labs Ltd



Hydroxyurea's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Hydroxyurea Generic API Manufacturers

Several generic applications have been filed for Hydroxyurea. The first generic version for Hydroxyurea was by Roxane Laboratories Inc and was approved on Aug 18, 1995. And the latest generic version is by Qilu Pharmaceutical Co Ltd and was approved on Mar 6, 2024.

Given below is the list of companies who have filed for Hydroxyurea generic, along with the locations of their manufacturing plants worldwide.